New pill could help men keep their hair
NCT ID NCT06972264
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tests an oral drug called VDPHL01 in 480 men aged 18-65 with mild to moderate male pattern baldness. The study is double-blind and placebo-controlled, lasting about 13 months. Researchers will measure hair counts and patient satisfaction at 6 months to see if the drug works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VDPHL01 (oral tablet)
What this could lead to
If it works, this could provide a new oral treatment option for male pattern baldness, potentially slowing hair loss and promoting regrowth.
What could go wrong
This is a Phase 3 trial, but results are not yet available. The drug may not work better than placebo, and side effects are possible. It is not a cure—treatment would likely need to continue long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 51
Austin, Texas, 78759, United States
-
Site 52
Louisville, Kentucky, 40241, United States
-
Site 53
Clarksville, Indiana, 47129, United States
-
Site 54
Ocala, Florida, 34470, United States
-
Site 55
Plainfield, Indiana, 46168, United States
-
Site 57
Portland, Oregon, 97210, United States
-
Site 59
Quincy, Massachusetts, 02169, United States
-
Site 60
Anderson, South Carolina, 29625, United States
-
Site 61
Chicago, Illinois, 60611, United States
-
Site 62
Coral Gables, Florida, 33146, United States
-
Site 63
Norfolk, Virginia, 23502, United States
-
Site 64
Manhattan Beach, California, 90266, United States
-
Site 66
Santa Monica, California, 90404, United States
-
Site 67
Dallas, Texas, 75230, United States
-
Site 68
Clinton Township, Michigan, 48038, United States
-
Site 69
Encino, California, 91436, United States
-
Site 70
Mill Creek, Washington, 98012, United States
-
Site 71
Boca Raton, Florida, 33486, United States
-
Site 72
Cincinnati, Ohio, 45236, United States
-
Site 73
Birmingham, Alabama, 35209, United States
-
Site 74
College Station, Texas, 77845, United States
-
Site 75
New Orleans, Louisiana, 70124, United States
-
Site 76
Austin, Texas, 78746, United States
-
Site 77
Phoenix, Arizona, 85006, United States
-
Site 78
Plano, Texas, 75024, United States
-
Site 79
Leawood, Kansas, 66211, United States
-
Site 80
Chestnut Hill, Massachusetts, 02467, United States
-
Site 81
East Greenwich, Rhode Island, 02818, United States
-
Site 82
Hickory, North Carolina, 28602, United States
-
Site 83
Troy, Michigan, 48084, United States
-
Site 84
Glenn Dale, Maryland, 20769, United States
-
Site 85
Norfolk, Virginia, 23502, United States
-
Site 86
Coral Gables, Florida, 33134, United States
-
Site 87
Rockville, Maryland, 20850, United States
-
Site 88
San Antonio, Texas, 78218, United States
-
Site 89
Birmingham, Alabama, 35244, United States
-
Site 90
Sandy Springs, Georgia, 30328, United States
-
Site 91
Sugarland, Texas, 77479, United States
-
Site 92
Huntersville, North Carolina, 28078, United States
-
Site 93
Northridge, California, 91324, United States
-
Site 94
Thousand Oaks, California, 91320, United States
-
Site 95
Hermitage, Tennessee, 37076, United States
-
Site 96
Tamarac, Florida, 33321, United States
-
Site 99
Miami, Florida, 33173, United States